Sir Andrew Witty was named president, UnitedHealth Group, in November 2019, in addition to his role as chief executive officer of Optum. As UnitedHealth Group president, Sir Andrew is responsible for enterprise business strategy formulation, enterprise business development and partnerships, and oversight of enterprise research and development and clinical capacities.

Witty was named executive vice president, UnitedHealth Group, and chief executive officer, Optum, in March 2018. He is also a member of the Office of the Chief Executive and previously served as a UnitedHealth Group company director.

From 2008 to 2017, Witty was chief executive officer and a director of the leading pharmaceutical manufacturer GlaxoSmithKline (GSK). He joined GSK in 1985, and prior to being named CEO, served as president of GSK Europe.

Witty is former chancellor of the University of Nottingham, a British public research university, and serves on the Singapore Prime Minister’s Research, Innovation and Enterprise Council. He is an advisor to 8VC and Hatteras Venture Partners, as well as to the Bill and Melinda Gates Foundation.

Witty was knighted in 2012 for services to the U.K. economy. In 2017, he was named an Honorary Citizen by Singapore for his contributions to the country’s growth and development.

Witty recently took a leave of absence from his current role as president, UnitedHealth Group and CEO of Optum to co-lead the World Health Organization (WHO) COVID-19 vaccine program.